ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C / Kucherenko A., Pampukha V., Bobrova I., Moroz L., Livshits L. (2015)
UkrainianEnglish

інтернет-адреса сторінки: http://jnas.nbuv.gov.ua/article/UJRN-0000683039
  Цитология и генетика      А - 2019  /     Випуск (2015, Т. 49, № 2)

Kucherenko A., Pampukha V., Bobrova I., Moroz L., Livshits L.
ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C

Cite:
Kucherenko, A., Pampukha, V., Bobrova, I., Moroz, L., Livshits, L. (2015). ITPA gene variant may protect against anemia induced during pegylated interferon alfa and ribavirin combination treatment in Ukrainian patients with chronic hepatitis C. Cytology and genetics, 49 (2), 38-41. http://jnas.nbuv.gov.ua/article/UJRN-0000683039

 

Інститут інформаційних технологій НБУВ

+38 (044) 525-36-24
libnas@nbuv.gov.ua
Голосіївський просп., 3, к. 209
м. Київ, 03039, Україна